MI
MaRS Investment Accelerator Fund
Venture CapitalActiveIAF is Canada's most active early stage venture capital firm, investing in B2B software, Fintech and Digital Health companies.
194
Investments
5
Exits
$100M
AUM
2.6%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for MaRS Investment Accelerator Fund.
Investment Thesis & Strategy
MaRS IAF invests in early-stage B2B software, fintech, and digital health companies, leveraging its position as a leading Canadian venture capital firm.
Investment Activity
Deals per year over the last 6 years
2
20163
20175
20181
20190
20201
2021Portfolio Companies
Selected investments from their portfolio of 194 companies
K
Kiite
SaaS · Series A, 2021
W
Winterlight Labs
Healthcare · Series A, 2019
B
BenchSci
Biotech · Series B, 2018
N
Nudge.ai
SaaS · Series A, 2018
M
Mylo
Fintech · Series A, 2018
B
BlueDot
Healthcare · Series A, 2018
B
Bridgit
SaaS · Series A, 2018
S
Sensorsuite
IoT · Series A, 2017
D
Deep Genomics
Biotech · Series A, 2017
I
Integrate.ai
AI/ML · Series A, 2017
F
Flybits
Enterprise · Series B, 2016
C
Clearbanc
Fintech · Series A, 2016
Notable Exits
CompanyTypeYearValue / Acquirer
Deep GenomicsAcquisition2024—
Blue J LegalAcquisition2023—
Integrity SolutionsAcquisition2022—
Nudge.aiAcquisition2022—
RubikloudAcquisition2018—
Frequently Asked Questions
MaRS Investment Accelerator Fund focuses on Series A, Series B, Series C+ stage investments.